COR vs EFX · P/E 21, rev $321.33B vs P/E 54, rev $5.68B
Cencora Inc. (COR) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
COR currently screens at market cap $53.91B and trailing P/E 21.2. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the COR and EFX stock pages for the full models.
Not investment advice.